Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
| ▸ | CDC25B | P30305 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CDC25A | P30304 | 1/20 | 0.45 |
| ▸ | CDC25C | P30307 | 1/20 | 0.45 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL258569 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL58853 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL60601 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL3174756 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL33526666 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL284843 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL9619173 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL29448238 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL29615063 | 1.00 | SLC16A3 (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG | |
| SCHEMBL381831 | 0.98 | HPGD (0.46) | SLC16A3KDM4EKMT2AL3MBTL1LIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 723 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119286570-A | Preparation method of aromatic amine oligomeric coupling antioxidant and lubricating oil composition | 中国石油化工股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-114752430-B | Vacuum pump oil | 出光兴产株式会社 | 2023-06-09 | — | — | CN | claimed |
| CN-109477029-B | Vacuum pump oil | 出光兴产株式会社 | 2022-06-17 | — | — | CN | claimed |
| CN-110392730-B | Mineral oil base oil and vacuum pump oil | 出光兴产株式会社 | 2022-04-26 | — | — | CN | claimed |
| US-9321721-B2 | Kinase inhibitors | ALLERGAN, INC. (US) | 2016-04-26 | — | — | US | claimed |
| WO-2014138452-A1 | KINASE INHIBITORS | ALLERGAN, INC. (US) | 2014-09-12 | — | — | WO | claimed |
| US-20140256819-A1 | KINASE INHIBITORS | ALLERGAN, INC. (US) | 2014-09-11 | — | — | US | claimed |
| EP-0885192-B8 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) | 2012-05-16 | — | — | EP | claimed |
| US-8163759-B2 | Pyrazolo[1,5-A] pyrimidine compounds as CB1 receptor antagonist | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2012-04-24 | — | — | US | claimed |
| US-20110140049-A1 | Corrosion Inhibitor Intensifier Compositions | HALLIBURTON ENERGY SERVICES, INC. | 2011-06-16 | — | — | US | claimed |
| US-5278165-A | Oxazolyl imidazol[4,5-b]pyridin and pyrimidine compounds | JANSSEN PHARMACEUTICA N.V. (BE) | 1994-01-11 | — | — | US | claimed |
| US-5217980-A | Antiallergens | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-06-08 | — | — | US | claimed |
| US-5081152-A | AZULENE DERIVATIVES AS THROMBOXANE A2 AND PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST | KOTOBUKI SEIYAKU CO., LTD. (JP) | 1992-01-14 | — | — | US | claimed |
| EP-0208621-B1 | SUBSTITUTED AMIDES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | RHONE-POULENC SANTE (FR) | 1989-04-12 | — | — | EP | claimed |
| US-4819057-A | METAL-ORGANIC FILMS-SEMICONDUCTOR JUNCTION | KABUSHIKI KAISHA TOSHIBA (JP) | 1989-04-04 | — | — | US | claimed |
| US-4720500-A | N-1,8-naphthyridin-2-yl amides useful as immunostimulants | RHONE-POULENC SANTE (FR) | 1988-01-19 | — | — | US | claimed |
| EP-0239444-A1 | Ferroelectric liquid crystal, process for its manufacture and its use in a liquid-crystal mixture | THOMSON-CSF (FR) | 1987-09-30 | — | — | EP | claimed |
| EP-0218422-A2 | Semiconductor light-emitting element | KABUSHIKI KAISHA TOSHIBA (JP) | 1987-04-15 | — | — | EP | claimed |
| EP-0073143-A2 | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | Ryan, James Walter (US) | 1983-03-02 | — | — | EP | claimed |
| US-3998834-A | ANALGESICS | JANSSEN PHARMACEUTICA N.V. (BE) | 1976-12-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256819-A1 | KINASE INHIBITORS | CDK1, MAP3K1, MAPK1 | SLC16A3 4776/4885KDM4E 1440/4885KMT2A 2223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.